Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended January 31, 2002
Business Overview: The Company operates in two primary segments: Laboratory Products and Technical Products. The Laboratory segment serves industrial research and education markets, while the Technical segment serves the high-tech sector.
Key Financial Metrics
| Metric ($ in thousands) | 3 Months Ended Jan 31, 2002 | 9 Months Ended Jan 31, 2002 |
|---|---|---|
| Net Sales | $20,798 | $63,063 |
| Gross Profit | $3,685 | $10,826 |
| Gross Margin | 17.7% | 17.2% |
| Operating Earnings | $604 | $2,135 |
| Net Earnings | $416 | $1,347 |
| Earnings Per Share (Diluted) | $0.17 | $0.54 |
| Cash from Operations (9mo) | $581 | |
| Working Capital | $15,909 (as of Jan 31, 2002) | |
| Short-Term Borrowings | $1,471 (outstanding under $6.0M credit facility) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18.0% for the quarter and 8.0% for the nine-month period compared to the prior year.
- Segment Performance:
- Laboratory Products: Sales increased 34.9% (quarter) and 26.0% (nine months), driven by strong industrial research and education markets.
- Technical Products: Sales declined 56.5% (quarter) and 60.9% (nine months) due to a depressed high-tech sector.
- Profitability: Operating earnings improved significantly to $604,000 for the quarter (vs. $82,000 prior year) and $2.1 million for the nine months (vs. $1.8 million prior year).
- One-Time Items: The prior year included a $391,000 charge related to a dispute with a general contractor, which is not present in the current period.
- Tax Rate: The effective tax rate decreased to 24.1% (quarter) and 32.6% (nine months) from 36% in the prior year, largely due to state income tax credits for machinery investments.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes funds from operations and short-term borrowings are sufficient to support ongoing business and capital expenditures through the current fiscal year. The current ratio stands at 2.4-to-1.
- Capital Expenditures: The Company utilized $1.3 million for capital expenditures in the first nine months, primarily for production equipment.
- Risks: Forward-looking statements are subject to economic, competitive, governmental, and technological factors. The Company notes that the high-tech sector remains depressed, impacting the Technical Products segment.
- Dividends: The Company paid $519,000 in dividends during the nine-month period.
Investor Verification Checklist
- Verify the sustainability of the 34.9% growth in the Laboratory Products segment given the cyclical nature of industrial research markets.
- Assess the long-term impact of the 60.9% decline in Technical Products sales on future revenue mix and margins.
- Confirm the utilization of the $6.0 million revolving credit facility, noting $1.471 million is currently outstanding.
- Review the specific machinery and equipment qualifying for the state income tax credits that lowered the effective tax rate.
- Monitor accounts receivable, which increased by $2.6 million in the nine-month period, impacting operating cash flow.